Volume 19 - Issue 9 - September 1, 2011

Two recent studies examine the safety and efficacy of this acne treatment. The first, from researchers at NorthShore University Health System in Evanston, IL, and the UNC Chapel Hill Department of Dermatology, aimed to determine if higher cumulative doses of isotretinoin would result in fewer incidences of treatment failure. The second, from a team at UC San Diego School of Medicine, evaluates the use of a patient symptom survey for monitoring and treating side effects related to isotretinoin.